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Clostridium difficile causes neonatal enteritis in piglets; 
strains of PCR ribotype 078 are most commonly identified. 
We investigated C. difficile prevalence in piglets in Australia 
and isolated a novel strain with a unique pathogenicity lo-
cus. In a mouse infection model, this strain produced more 
weight loss than did a ribotype 078 strain.
Clostridium difficile is the causative agent of severe enteritis (“scouring”) in neonatal piglets 1–7 days of 
age throughout Canada, the United States, and Europe (1). 
Although deaths attributable to C. difficile infection (CDI) 
generally are low because of good stockmanship, piglets 
that survive CDI remain 10%–15% underweight on aver-
age and take additional time to wean (2).
Colonization frequency of C. difficile in scouring pig-
lets is as high as 52%; this rate declines to 4% by 2 months 
of age (3). C. difficile is also commonly found in feces 
from apparently healthy piglets, which contributes to en-
vironmental contamination. Widespread air and surface 
contamination of the piggery environment with C. difficile, 
presumably in the form of long-surviving spores, may play 
a role in the epidemiology of CDI in pigs and subsequent 
community-acquired infection in humans (4). 
In Europe and the United States, the genotypes of C. 
difficile isolates that cause disease in humans and produc-
tion animals overlap, particularly PCR ribotype 078, which 
predominates in pigs worldwide. This ribotype is increas-
ing in prevalence and associated with severe community-
acquired CDI in humans geographically located near pig 
farms (5). C. difficile has also been found in retail food, 
including meat products, seafood, and vegetables (6). 
C. difficile in piglets in Australia has not been system-
atically investigated, despite reports of idiopathic enteritis 
nationwide. It is likely that that C. difficile strains in pig-
lets in Australia are different from those found in the rest 
of the world because of Australia’s geographic isolation, 
strict quarantine laws regarding importation of livestock, 
and low human population and pig density. We studied C. 
difficile prevalence in scouring neonatal piglets and evalu-
ated a novel strain of C. difficile isolated from these piglets 
by using multiple identification methods.
The Study
Rectal swab specimens were collected during July–
November 2009 from 185 neonatal piglets on 3 farms that 
were experiencing scouring problems. The farms were lo-
cated at 2 geographic locations in Western Australia (20 
km apart) and were owned by a commercial farrow-to-
finish operation. At the time of the study, 50%–80% of lit-
ters were scouring, with death rates of 11%–14%. The sick 
piglets had early-onset, nonhemorrhagic, yellow, pasty-
to-watery diarrhea; disease course without treatment was 
ill-thrift, anorexia, dehydration, and death. Healthy pig-
lets were treated prophylactically at 1–3 days of age with 
amoxicillin or penicillin. 
Of the 185 piglets, 131 were on 2 farms at the same 
geographic location that had the most severe scouring 
problems. The remaining 54 piglets were on a high bios-
ecurity farm at a separate location with a variable scour-
ing problem; 11 of these animals were asymptomatic. Test 
results for Escherichia coli, rotavirus, and C. perfringens 
were negative for all animals; we did not test for porcine 
reproductive and respiratory syndrome virus or transmissi-
ble gastroenteritis coronavirus because they are considered 
exotic (i.e., no reported outbreaks) in Australia.
Samples were cultured directly onto cycloserine cefox-
itin fructose agar and incubated anaerobically at 37°C for 
48 h. The swabs were then inoculated into a Robertson’s 
cooked-meat selective enrichment broth and incubated an-
aerobically at 37°C for 7 days; spores were then selected 
by alcohol shock (1:1 with anhydrous ethanol). The spores 
were then cultured onto cycloserine cefoxitin fructose agar 
with 0.1% taurocholic acid added. Putative C. difficile 
colonies were subcultured onto prereduced blood agar and 
identified by Gram stain, characteristic colony morphol-
ogy, and smell.
Toxin profiling was by PCR detection of the toxin A 
(tcdA), toxin B (tcdB), and binary toxin (cdt) genes (7,8). 
Isolates underwent PCR ribotyping and were compared 
with human reference C. difficile strains from Australia and 
international ribotypes from the Anaerobe Reference Labo-
ratory (Cardiff, Wales, UK) (9). Genome shotgun sequenc-
ing of a representative isolate (designated strain AI35) 
was performed by using the Illumina HiSeq2000 platform 
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(Australian Genome Research Facility, The Walter and 
Eliza Hall Institute of Medical Research, Parkville, Vic-
toria, Australia). Paired-end reads of 31,085,914 bp were 
assembled into 117 contigs by using the Velvet software 
suite (10).
Toxin B quantitation was performed by using a Vero 
cell cytotoxicity assay (11). Vero cells were exposed to se-
rial 2-fold dilutions of C. difficile cell-free culture superna-
tants from a ribotype 027 human strain (M7404), a ribotype 
078 animal strain (JGS6133), and strain AI35. C. difficile 
strain 630, a recognized low-toxin producer, was included 
as a control. After the cultures were incubated overnight at 
37°C in 5% CO2, morphologic changes were examined by 
microscopy. The endpoint was scored as the last dilution at 
which 100% cytopathic effect was observed. Assays were 
performed in triplicate on independent culture supernatants.
In vivo virulence was assessed by using a mouse mod-
el of CDI (12). Specifically, 6–8-week-old male C57/B6 
mice (5 mice per strain) were force-fed 1 × 107 spores of the 
same C. difficile strains used in the Vero cell assays. Mice 
were housed in separate cages to avoid cross-contamination 
and monitored daily for weight loss and signs of disease.
Of the 185 piglets tested, C. difficile was isolated from 
114 (62%): 70 (53%) of 131  piglets from the herds with 
severe scouring, 33 (77%) of 43  piglets from the herd with 
variable scouring, and 11 (100%) of 11  asymptomatic pig-
lets. Isolates were clonal; all were novel PCR ribotype 237 
and had a toxin profile of tcdA–tcdB+cdtA+cdtB+. 
Genome sequencing of strain AI35 showed a novel 
pathogenicity locus (PaLoc) structure (Figure 1). A large 
deletion had removed the tcdA and tcdC genes and a por-
tion of the adjacent cdd1 gene located outside the PaLoc. 
Strain AI35 also encoded a variant TcdE. The AI35 binary 
toxin locus was complete and contained an intact copy of 
cdtR, unlike ribotype 078 isolates, which encode a cdtR 
with a premature stop codon. Strain AI35 may therefore 
be a more proficient binary toxin producer than ribotype 
078 strains. Despite these variations, multilocus sequence 
typing showed that strain AI35 belongs to the same clade 
(clade 5) and sequence type (11) as ribotype 078 strains 
[strain AI15 in the report by Stabler et al. (13) is the same 
ribotype as AI35].
In vitro testing showed AI35 produced »25-fold less 
toxin B than did the ribotype 027 (p = 0.0354 by t test) and 
ribotype 078 (p = 0.0074 by t test) isolates, but AI35 showed 
similar toxin levels to the low toxin producing strain 630. 
AI35-mediated cytopathic effect on Vero cells was similar 
to that reported for the lethal toxin of C. sordellii and C. dif-
ficile strain 8864, a toxin A–B+ human strain with mutations 
affecting its glucosylation substrate specificity (14). Strain 
M7404 (ribotype 027) was significantly more virulent than 
strain AI35 (p = 0.0001 by log-rank [Mantel Cox] test) and 
strain JGS6133 (p = 0.0002 by log-rank [Mantel Cox] test). 
All mice infected with strain M7404 died (Figure 2, panel 
A), but mice infected with strains AI35 and JGS6133 sur-
vived (Figure 2, panel A). Still, despite low toxin produc-
tion, AI35 caused significantly greater weight loss in mice 
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Figure 1. Structure of pathogenicity locus (PaLoc) and flanking 
regions in Clostridium difficile strains AI35 and VPI10463. 
Boxes indicate open reading frames; arrows indicate direction 
of transcription. Encoded genes are indicated above the arrows. 
Figure not drawn to scale.
Figure 2. A) Survival and B) percentage of weight lost in mice over 4 days after infection with Clostridium difficile. Male C57/B6 mice were 
infected with C. difficile spores for strains M7404 (triangles), JGS6133 (078) (diamonds), or A135 (circles); phosphate-buffered saline 
(squares) was used as control. Error bars in panel B indicate SEM.
than did the ribotype 078 strain JGS6133 (p = 0.0011 by 
analysis of variance) (Figure 2, panel B). This difference 
may be the result of production of a variant toxin; similar 
toxins were 8-fold more toxic to mice than was toxin B 
produced by strain VPI10463 (15).
Conclusions
Our results show that a toxigenic C. difficile strain cir-
culating in piglets in Australia is of a different ribotype, 237, 
than that commonly found in other parts of the world. The 
strain we found contained a unique PaLoc and produced 
more weight loss in mice than did the more common ribotype 
078 animal strain. Identifying this strain is the first step in de-
tecting and responding to this emerging disease in piglets in 
Australia. Future studies in swine will focus on nationwide 
prevalence, laboratory detection, and epidemiologic investi-
gation to understand the transmission cycle in pigs and any 
relationship between animal and human disease.
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